[2009] HCATrans 324
IN THE HIGH COURT OF AUSTRALIA
Office of the Registry
Sydney No S135 of 2009
B e t w e e n -
ALPHAPHARM PTY LTD
Applicant
and
H LUNDBECK A/S
First Respondent
LUNDBECK AUSTRALIA PTY LTD
Second Respondent
Office of the Registry
Sydney No S151 of 2009
B e t w e e n -
ARROW PHARMACEUTICALS PTY LTD (ACN 003144170)
Applicant
and
H LUNDBECK A/S
Respondent
Office of the Registry
Sydney No S164 of 2009
B e t w e e n -
H LUNDBECK A/S
First Applicant
LUNDBECK AUSTRALIA PTY LTD (ACN 070 094 290)
Second Applicant
and
ALPHAPHARM PTY LTD (ACN 002 359 739)
Respondent
Office of the Registry
Sydney No S165 of 2009
B e t w e e n -
H LUNDBECK A/S
Applicant
and
ARROW PHARMACEUTICALS PTY LTD (ACN 003 144 170)
Respondent
Office of the Registry
Sydney No S166 of 2009
B e t w e e n -
H LUNDBECK A/S
Applicant
and
COMMISSIONER OF PATENTS
First Respondent
ALPHAPHARM PTY LTD (ACN 002 359 739)
Second Respondent
Applications for special leave to appeal
FRENCH CJ
GUMMOW J
TRANSCRIPT OF PROCEEDINGS
AT SYDNEY ON FRIDAY, 11 DECEMBER 2009, AT 11.04 AM
Copyright in the High Court of Australia
__________________
MR D.K. CATTERNS, QC: May it please the Court, I appear with my learned friend, MR S.C.G. BURLEY, SC, for Alphapharm. We are the applicants in the first matter, the respondents in the third, and the second respondent in the fifth. (instructed by Mallesons Stephen Jaques)
MR D. SHAVIN, QC: May it please the Court, I appear with my learned friend, MS K.J. HOWARD, SC, for H. Lundbeck A/S and Lundbeck Australia Proprietary Limited. We are respondents in the first two matters and applicants in the next three. (instructed by Corrs Chambers Westgarth)
MR C. DIMITRIADIS: May it please the Court, I appear with my learned friend, MR P.A. MADDIGAN, for Arrow Pharmaceuticals Proprietary Limited, which is the applicant in the second matter and the respondent in the fourth matter. (instructed by Blake Dawson)
FRENCH CJ: I note there is a submitting appearance for the Commissioner of Patents. Yes, Mr Catterns.
MR CATTERNS: May it please the Court. Of course it is a matter for the Court’s convenience, but as we see it there are two separate matters. One is the construction matter ‑ ‑ ‑
FRENCH CJ: Yes, there is the construction question and then the construction question.
MR CATTERNS: Yes, relating to patent extension.
FRENCH CJ: Yes.
MR CATTERNS: For our part, if the Court is not inconvenienced, my learned friend, Mr Burley, was going to deal with the patent extension point and I was going to deal with the construction point. As to that, your Honours – and that is the first matter, and my learned friend, Mr Dimitriadis, is on our side in that same matter – in his second matter – your Honours, we respectfully ‑ ‑ ‑
GUMMOW…
Keep reading for free
Create a free CaseChat account to read Alphapharm Pty Ltd v H Lundbeck A-s & Anor and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2009] HCATrans 324
- Decision Date
CaseChat Overview and Summary
The central legal issues before the High Court were whether the conduct of the respondents in entering into agreements with pharmacists constituted exclusive dealing, and whether this conduct, or other aspects of their market behaviour, amounted to a misuse of market power. The Court was required to interpret the relevant provisions of the *Trade Practices Act 1974* concerning exclusive dealing and the prohibition against misuse of market power, and to determine whether the facts established breaches of these provisions.
The High Court, in its joint judgment, analysed the nature of the agreements between the respondents and pharmacists. It found that the agreements did not, on their proper construction, impose conditions that prevented the pharmacists from acquiring goods from Alphapharm or dealing with competitors of the respondents. Consequently, the Court held that the conduct did not amount to exclusive dealing under the Act. Furthermore, the Court found no evidence to support the claim of misuse of market power, concluding that the respondents' actions were not such as to substantially lessen competition in the relevant market. The appeal was therefore dismissed.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.